DNA testing of suspected cannabis samples with exceptional morphology using a simple detection kit

Interpol Review of Drug Analysis 2019-2022

“…2019 identification of four functional SNPs that are likely to induce decreased THCAS activity in the fiber-type cannabis plants [ 409 ]; 2020 review of genomics of cannabis [ 410 ]; analysis of plastomes for genetic identification and characterization of drug and nondrug-types of Cannabis [ 411 ]; evaluation of the effectiveness and efficiency of two STR multiplex systems to individualize and differentiate seized Cannabis sativa samples by geographic region [ 412 ]; two highly polymorphic regions of the chloroplast genome of C. sativa, tps16 and clpP, to be used for determination of crop type and biogeographical origin [ 413 ]; determination of the genetic composition of ten drug seizures of Cannabis using PCR combined with a high resolution melting (HRM) strategy and a barcoding marker (ITS) [ 414 ]; high-throughput PACE (PCR Allele Competitive Extension) assays for C. sativa plant sex and cannabinoid chemotype [ 415 ]; Simple Sequence Repeats (SSRs) for determination of technical Cannabis cultivars and genetic variability [ 416 ]; characterization of cannabinoid content and investigation of CBDAS genotypes of >300 feral C. sativa plants [ 417 ]; 2021 investigation of the ancestry of a new cultivar and cannabinoid synthase genes in relation to cannabinoid inheritance [ 418 ]; genetic engineering methods in cannabis [ 419 ]; assessment of the genetic and phenotypic consistency in available high-CBD hemp varieties of seed or clones from 22 different named accessions meant for commercial production [ 420 ]; review of the history of Cannabis and the molecular pathways that underpin the production of key secondary metabolites that may confer medical efficacy [ 421 ]; investigation of the genetic identity of Cannabis supplied by National Institute on Drug Abuse (NIDA) relative to common categories within the species including wild Hemp (feral; 6) and cultivated Hemp (3), CBD drug type (3), and high THC drug type subdivided into Sativa (11), Hybrid (14), and Indica (10) [ 422 ]; study of how genetics effect cannabinoid content [ 423 ]; genetic study investigating phytochemistry, reproductive traits, growth architecture, and leaf morphology from 297 hybrid individuals from a cross between two diverse lineages [ 424 ]; genomic analysis of multiple Cannabis varieties from diverse lineages including two produced by NIDA [ 425 ]; identification and loci mapping of 69 loci associated with agronomic (34) and biochemical (35) trait variation [ 426 ]; DNA testing using a simple kit on suspected cannabis samples with exceptionally shaped leaves [ 427 ]; 2022 study of 73 Cannabis sativa whole-genome shotgun libraries to reveal eight different mtDNA haplotypes [ 428 ]; optimization and evaluation of a previously reported single nucleotide polymorphism (SNP) assay for determining C. sativa crop type to distinguish between marijuana and hemp [ 429 ...…”